Evidence map›Paper›PMID 26584636›Full record

ArticleNature communications2015

Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.

Andrew J Whittle, Meizi Jiang, Vivian Peirce, Joana Relat, Sam Virtue, Hiroyuki Ebinuma, Isamu Fukamachi, Takashi Yamaguchi, Mao Takahashi, Takeyoshi Murano and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. LR11/SorLA and its role in cardiovascular disease.International journal of cardiology. Heart & vasculature · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 5 countries.

Andrew J WhittleUniversity of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 OQQ, UK.
Meizi JiangDepartment of Clinical-Laboratory and Experimental-Research Medicine, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Vivian PeirceUniversity of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 OQQ, UK.
Joana RelatDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Barcelona, and Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona 08028, Spain.
Sam VirtueUniversity of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 OQQ, UK.
Hiroyuki EbinumaTsukuba Research Institute, Sekisui Medical Co. Ltd., Ryugasaki 301-0852, Japan.
Isamu FukamachiTsukuba Research Institute, Sekisui Medical Co. Ltd., Ryugasaki 301-0852, Japan.
Takashi YamaguchiCenter for Diabetes, Endocrinology and Metabolism, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Mao TakahashiCardiovascular Center, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Takeyoshi MuranoDepartment of Clinical-Laboratory and Experimental-Research Medicine, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Ichiro TatsunoCenter for Diabetes, Endocrinology and Metabolism, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Masahiro TakeuchiDepartment of Hematology, Chiba University Hospital, Chiba 260-8677, Japan.
Chiaki NakasekoDepartment of Hematology, Chiba University Hospital, Chiba 260-8677, Japan.
Wenlong JinDepartment of Endocrinology, Affiliated Hospital of Yanbian University, Yanji 133000, China.
Zhehu JinDepartment of Dermatology, Affiliated Hospital of Yanbian University, Yanji 133000, China.
Mark CampbellUniversity of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 OQQ, UK.
Wolfgang J SchneiderDepartment of Medical Biochemistry, Medical University of Vienna, Max F. Perutz Laboratories, Vienna 1030, Austria.
Antonio Vidal-PuigUniversity of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 OQQ, UK.
Hideaki BujoDepartment of Clinical-Laboratory and Experimental-Research Medicine, Toho University, Sakura Medical Center, Sakura 285-8741, Japan.
Toho University · JPWellcome/MRC Institute of Metabolic Science · GBChiba University Hospital · JPSekisui Medical (Japan) · JPYanbian University · CNAddenbrooke's Hospital · GBChiba University · JPMax Perutz Labs · ATToho University Medical Center Sakura Hospital · JPUniversitat de Barcelona · ESWellcome Sanger Institute · GB

Funding

British Heart Foundation PG/12/53/29714Medical Research Council MC_UU_12012/2Medical Research Council MC_UU_12012/5Wellcome Trust
6 · The paper itself

Abstract

Thermogenesis in brown adipose tissue (BAT) is an important component of energy expenditure in mammals. Recent studies have confirmed its presence and metabolic role in humans. Defining the physiological regulation of BAT is therefore of great importance for developing strategies to treat metabolic diseases. Here we show that the soluble form of the low-density lipoprotein receptor relative, LR11/SorLA (sLR11), suppresses thermogenesis in adipose tissue in a cell-autonomous manner. Mice lacking LR11 are protected from diet-induced obesity associated with an increased browning of white adipose tissue and hypermetabolism. Treatment of adipocytes with sLR11 inhibits thermogenesis via the bone morphogenetic protein/TGFβ signalling pathway and reduces Smad phosphorylation. In addition, sLR11 levels in humans are shown to positively correlate with body mass index and adiposity. Given the need for tight regulation of a tissue with a high capacity for energy wastage, we propose that LR11 plays an energy conserving role that is exaggerated in states of obesity.

Indexed as

ThermogenesisAdipose Tissue, BrownAnimalsBody Mass IndexDown-RegulationEnergy MetabolismFemaleHumansLDL-Receptor Related ProteinsMaleMembrane Transport ProteinsMiceMice, Inbred C57BLMice, KnockoutObesityReceptors, LDLLDL-Receptor Related ProteinsMembrane Transport ProteinsReceptors, LDLSORL1 protein, humanSorl1 protein, mouse

Identifiers

PMID26584636
PMCPMC4673879
OpenAlexW2180148932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.